| Returns | 1W : 2.7% , 1M : 26.9%,1Y : 221.4% |
| Peers & Returns | 1W | 1M | 1Y |
| BROOKS LABORATORIES | 2.7% | 26.9% | 221.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 3.4% | 6.4% | 39.2% |
| DR REDDYS LABORATORIES | -0.4% | 11.7% | 26.7% |
| DIVIS LABORATORIES | 0.6% | 12.6% | 59.7% |
| CIPLA | 4.8% | 19.4% | 56.3% |
| BIOCON | 0.6% | 3.5% | 18% |
| AUROBINDO PHARMA | 5.4% | 14.8% | 74.8% |
| LUPIN | 1.5% | 0.6% | 27.8% |
| TORRENT PHARMACEUTICALS | 1.6% | 5% | 12.5% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
-
P/E Calculated based on EPS of -9.87
[ Mar2020 - Standalone Results ] 1.81
P/B Calculated based on Book Value of 39.84
[ Mar2020 - Standalone Results ] 2.72
P/S Calculated based on Revenues of 65.332 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
NA 92% 268% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
